cancer treatment
By testing multiple chemotherapies on a patient's cancer cells before treating a cancer patient, ChemoFx helps determine the chemotherapies that are more likely to be effective and helps guide the physician away from therapies that are more likely to be ineffective- giving patients a powerful advantage in the fight against gynecologic cancer.
New Data Shows Unparalleled Overall Survival Improvement with ChemoFx!

Data recently published by the journal Gynecologic Oncology shows ChemoFx® results were associated with a 14 month increase (65% improvement) in overall survival and a 50% improvement in progression-free survival - to learn more about this exciting data, physicians, CLICK HERE! If you are a patient or care giver, CLICK HERE!

Follow Me!

What is ChemoFx?

ChemoFx is a drug response marker. It's a test that quantifies an individual gynecologic cancer patient's probable tumor response to various chemotherapeutic and biologic agents—providing both sensitivity and resistance information. While not intended to replace standard of care therapy, ChemoFx provides valuable insights that help guide physicians' treatment decisions and give both physicians and patients an edge against gynecologic cancer.

Product of Precision Therapeutics

Each and every patient's cancer is unique. That's why we at Precision Therapeutics believe in ensuring that every patient receives treatment that is customized to his or her individual needs.

Our mission is simple: support physicians in their treatment decisions and improve the chances for a better quality of life for those living with cancer.
cancer treatment
cancer treatment